These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12858819)

  • 1. Physician interaction with pharmaceutical companies: the rules are getting tougher.
    Loomis CH
    J Okla State Med Assoc; 2003 Jun; 96(6):278-9. PubMed ID: 12858819
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical doctors and pharmaceutical industry].
    de Francisco AL
    Nefrologia; 2004; 24(5):393-4. PubMed ID: 15648899
    [No Abstract]   [Full Text] [Related]  

  • 4. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
    Norris RA
    Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
    [No Abstract]   [Full Text] [Related]  

  • 6. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine.
    Rubin EB; Bernat JL
    Headache; 2008; 48(10):1545-9. PubMed ID: 19076654
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 8. Use and perceptions of clinical practice guidelines by internal medicine physicians.
    Shea AM; DePuy V; Allen JM; Weinfurt KP
    Am J Med Qual; 2007; 22(3):170-6. PubMed ID: 17485558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
    Wilson A
    Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New contract recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians].
    Häser I; Hofmann A
    Orthopade; 2005 Mar; 34(3):263-4, 266. PubMed ID: 16247838
    [No Abstract]   [Full Text] [Related]  

  • 12. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of the pharmaceutical industry on treatment guidelines].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national survey of physician-industry relationships.
    Grande D
    N Engl J Med; 2007 Aug; 357(5):507-8; author reply 508. PubMed ID: 17674458
    [No Abstract]   [Full Text] [Related]  

  • 15. [New conduct recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians].
    Häser I; Hofmann A
    Anaesthesist; 2005 Mar; 54(3):263-7. PubMed ID: 15719243
    [No Abstract]   [Full Text] [Related]  

  • 16. "Good Publication Practice for Pharmaceutical Companies": where are we now?
    Wager E
    MedGenMed; 2005 Apr; 7(2):6. PubMed ID: 16369385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
    Ravindran GD
    Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 19. Snake oil and Caesar salad: the ethics of physician and pharmaceutical relationships.
    Woollard RF
    CMAJ; 1991 Oct; 145(8):931-3. PubMed ID: 1913426
    [No Abstract]   [Full Text] [Related]  

  • 20. ACOG Committee Opinion No. 401: Relationships with industry.
    American College of Obstetricians and Gynecologists Committee on Ethics
    Obstet Gynecol; 2008 Mar; 111(3):799-804. PubMed ID: 18310391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.